Reference Source

Otc Pharma Interna · 66-41 · NETHERLANDS

For Otc Pharma Interna · 66-41 · NETHERLANDS, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is NETHERLANDS; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is Edisonweg 22 , Gorinchem, Zuid-Holland NETHERLANDS, verified against its source on 2026-09-16.

Firm
Otc Pharma Interna verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
NETHERLANDS verified
Address
Edisonweg 22 , Gorinchem, Zuid-Holland NETHERLANDS verified
Date published
09/30/2009 verified
Product code
54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
FDA notes
10/9/2007. Diabe Cinn Capsules. This product is labeled for People with Type II diabetes treating the characteristic signs and symptoms (lowering blood sugar and increasing insulin activity) of this disease. | 10/9/2007. Diabe Cinn Capsules. This product is labeled for People with Type II diabetes treating the characteristic signs and symptoms (lowering blood sugar and increasing insulin activity) of this disease. each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Otc Pharma Interna Date Published : 09/30/2009 Edisonweg 22 , Gorinchem, Zuid-Holland NETHERLANDS 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 09/30/2009 Notes: 10/9/2007. Diabe Cinn Capsules. This product is labeled for People with Type II diabetes treating the characteristic signs and symptoms (lowering blood sugar and increasing insulin activity) of this disease. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/30/2009 Notes: 10/9/2007. Diabe Cinn Capsules. This product is labeled for People with Type II diabetes treating the characteristic signs and symptoms (lowering blood sugar and increasing insulin activity) of this disease.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.